Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort

Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort

Abstract Early noninvasive reliable biomarkers are among the major unmet needs in Parkinson’s disease (PD) to monitor therapy response and disease progression. Objective measures of motor performances could allow phenotyping of subtle, undetectable, early stage motor impairments of PD patients. This...

Full description

Bibliographic Details
Main Authors: Giulia Di Lazzaro, Mariachiara Ricci, Giovanni Saggio, Giovanni Costantini, Tommaso Schirinzi, Mohammad Alwardat, Luca Pietrosanti, Martina Patera, Simona Scalise, Franco Giannini, Antonio Pisani
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-021-00227-1

Internet

https://doi.org/10.1038/s41531-021-00227-1

Similar Items